Brind.

Ajax and Schrödinger expanded their research collaboration to include a new JAK target, utilizing advanced computational platforms.

1 report, 1 independent Updated Jul 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Ajax and Schrödinger expanded their research collaboration to include a new JAK target, utilizing advanced computational platforms.

Who's involved

What this event is mainly about
AjaxSchrödinger

Keep exploring

The entities involved

  • Ajax

    American car manufacturer

    Nothing else this week.

  • Schrödinger

    American life sciences company

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Business WireAjax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target NEW YORK & CAMBRIDGE, Mass., July 17, 2025--(BUSINESS WIRE)--Ajax Therapeutics, Inc. and Schrödinger,